2021 ESC EAPC Quality Indicators for ASCVD Prevention. ACR, albumin creatinine ratio; APT, antiplatelet therapy; ASCVD, atherosclerosis cardiovascular disease; Ax, assessment; BP, blood pressure; CAC, coronary calcium scoring; CE, cardioembolic; CKD,chronic kidney disease; CR, cardiac rehabilitation; CV, cardiovascular; CVH, cardiovascular hospitalization; DM, diabetes mellitus; ECG, electrocardiogram; eGFR, estimated glomerular filtration rate; GLP-1 RA, glucagon-like peptide-1 receptor agonists; HbA1c, glycated haemoglobin; HBR, high bleeding risk; HTN, hypertension; LDL-C, low-density lipoprotein cholesterol; MDT, multidisciplinary team; MI, myocardial infarction; PAD, peripheral artery disea; PPI, proton pump inhibitors; PREMs, patient-reported experience measures; RAASi, renin–angiotensin–aldosterone system inhibitors; Rx, treatment; SGLT2i, sodium/glucose cotransporter-2 inhibitors; TTE, transthoracic echocardiogram.